NCT00505700View on ClinicalTrials.gov

VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

September 30, 2005

Conditions
Leukemia
Interventions
DRUG

velcade

DRUG

Idarubicin

DRUG

Cytarabine

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Beth Israel/ Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
collaborator

Millennium Pharmaceuticals, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER